Sort
11,323 grants matching “glioblastoma”
A Multidisciplinary Center for Developing Human and Non-human Primate Brain Cell Atlases
$371,912Arnold Kriegstein · University Of California, San Francisco · UM1 · FY2024 · MH
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
$371,863Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2024 · CA
The hypoxic niche in glioblastoma is maintained by myeloid produced creatine
$371,848Jason Miska · Northwestern University At Chicago · R01 · FY2023 · CA
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
$371,734Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2014 · NS
Boston Children's Hospital and Beth Israel Deaconess Medical Center NeuroNEXT Clinical Research Site
$371,635Basil T Darras · Boston Children'S Hospital · U24 · FY2018 · NS
Transcriptional control of OPC fate specification and homing to gray matter and white matter in the CNS
$371,611Tou Yia Vue · University Of New Mexico Health Scis Ctr · R01 · FY2023 · NS
A Multipoint Injection Technology for Highly Efficient Convection-Enhanced Delivery of Gene-Based Therapeutics
$371,603Flavia Vitale · University Of Pennsylvania · R01 · FY2021 · NS
Plexin-B2 function in glioma invasion and glioma stem cell maintenance
$371,598Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · NS
The role of the LZTR1 ubiquitin ligase in stem cells and cancer
$371,586Antonio Iavarone · Columbia University Health Sciences · R01 · FY2019 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$371,552Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
A novel strategy to overcome the P-gp/BCRP drug efflux system at the blood-brain barrier to improve brain uptake of CNS therapeutics
$371,471Bjoern Bauer · University Of Kentucky · R01 · FY2018 · NS
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
$371,402Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2014 · AI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
$371,402Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2015 · AI
EGFR signaling network adaptations to overcome RAS-induced membrane stress in glioblastoma
$371,330Matthew J Lazzara · University Of Virginia · U54 · FY2025 · CA
RhoA and GPCR mediated transcriptional activation regulates glioblastoma
$371,309Joan Heller Brown · University Of California, San Diego · R01 · FY2019 · CA
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$371,300Adam M Sonabend · Northwestern University At Chicago · R01 · FY2020 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$371,300Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2020 · NS
Epigenetic regulation of temozolomide responsiveness in glioblastoma
$371,002Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2010 · CA
Deciphering mechanisms of perivascular tumor cell invasion in glioblastoma
$370,992Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$370,833Robert L Martuza · Massachusetts General Hospital · R01 · FY2012 · NS
Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
$370,789Frank Pajonk · University Of California Los Angeles · R01 · FY2016 · CA
Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
$370,789Frank Pajonk · University Of California Los Angeles · R01 · FY2017 · CA
Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
$370,789Frank Pajonk · University Of California Los Angeles · R01 · FY2018 · CA
Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
$370,789Frank Pajonk · University Of California Los Angeles · R01 · FY2020 · CA
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$370,781Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS